Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Diagnostics to accurately detect disease and monitor therapeutic response are essential for effective clinical management. Bioengineering, chemical biology, molecular biology, and computer science tools are converging to guide the design of diagnostics that leverage enzymatic activity to measure or produce biomarkers of disease. Here, we review recent advances in the development of these “activity-based diagnostics” and their application in infectious and noncommunicable diseases. We highlight efforts towards both molecular probes that respond to disease-specific catalytic activity to produce a diagnostic readout, as well as diagnostics that use enzymes as an engineered component of their sense-and-respond cascade. These technologies exemplify how integrating techniques from multiple disciplines with pre-clinical validation has enabled activity-based diagnostics that may realize the goals of precision medicine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507 · cited 1×
“An orthogonal CRISPRbased diagnostic system utilizes a distinct effector, Cas12a, that exhibits target-activated, nonspecific single-stranded DNA endonuclease (ssDNase) activity [115].”
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809 · cited 1×
“Advances in chemistry and nanotechnology have spawned both substrate cleavage-and binding-based probes for molecular imaging of enzymes involved in cancer (Figure 2).”
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Cohen, J. D., Li, L., Wang, Y., Thoburn, C., Afsari, B., Danilova, L., Douville, C., Javed, A. A., Wong, F., Mattox, A., et al. (2018) · Science · doi:10.1126/science.aar3247 · Cited by 2,783 · cited 1×
“Convergent efforts from bioengineering, chemical biology, and molecular biology have inspired a new class of smart diagnostics that leverage enzymatic activity to measure or produce biomarkers of disease.”
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Newman, A. M., Bratman, S. V., To, J., Wynne, J. F., Eclov, N. C. W., Modlin, L. A., Liu, C. L., Neal, J. W., Wakelee, H. A., Merritt, R. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3519 · Cited by 2,220
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900 · cited 1×
“Recent advances in molecular diagnostics have yielded promising assays for endogenous disease biomarkers, such as nucleic acids for viral infections [7], stool-based tests for colon cancer screening [8], and circulating tumor DNA (ctDNA) [9–12] for cancer, that can be used in conjunction with or as an alternative to i…”
Current and future perspectives of liquid biopsies in genomics-driven oncology
Heitzer, E., Haque, I. S., Roberts, C. E. S., & Speicher, M. R. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-018-0071-5 · Cited by 1,557 · cited 4×
“treatment efficacy or disease relapse because ctDNA levels are thought to scale with tumor burden [12].”
InfluentialBenzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis
Makarov, V., Manina, G., Mikusova, K., Möllmann, U., Ryabova, O., Saint-Joanis, B., Dhar, N., Pasca, M. R., Buroni, S., Lucarelli, A. P., et al. (2009) · Science · doi:10.1126/science.1171583 · Cited by 740 · cited 4×
“CDG-DNB3 is fi rst cleaved by a conserved Mtb β -lactamase to activate fl uorescence [75,81], and is then covalently modi fi ed by the Mtb essential enzyme DprE1 [82] to retain signal within the membrane.”
InfluentialAn ingestible bacterial-electronic system to monitor gastrointestinal health
Mimee, M., Nadeau, P., Hayward, A., Carim, S., Flanagan, S., Jerger, L., Collins, J., McDonnell, S., Swartwout, R., Citorik, R. J., et al. (2018) · Science · doi:10.1126/science.aas9315 · Cited by 606 · cited 1×
“For example, an ingestible bacterial–electronic microcapsule was recently developed and deployed for accurate in situ diagnosis of GI bleeding in swine [109].”
Cited by
Crosby, D., Bhatia, S., Brindle, K. M., Coussens, L. M., Dive, C., Emberton, M., Esener, S., Fitzgerald, R. C., Gambhir, S. S., Kuhn, P., et al. (2022) · Science · doi:10.1126/science.aay9040 · Cited by 1,379
“…nanoparticles have been developed that are cleaved by dysregulated protease activity in cancer cells or their microenvironments to generate urinary reporters ( 89 ), and cancer-associated enzymes can metabolize exogenous VOC probes to produce volatile reporters for non-invasive detection ( 87 ).”
Self-citationde Almeida, L. G. N., Thode, H., Eslambolchi, Y., Chopra, S., Young, D., Gill, S., Devel, L., & Dufour, A. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000349 · Cited by 535
Deep learning guided design of protease substrates
Martin-Alonso, C., Alamdari, S., Samad, T. S., Yang, K. K., Bhatia, S. N., & Amini, A. P. (2026) · Nature Communications · doi:10.1038/s41467-025-67226-1 · Cited by 14
Self-citationDeep learning guided design of protease substrates
Martin-Alonso, C., Alamdari, S., Samad, T. S., Yang, K. K., Bhatia, S. N., & Amini, A. P. (2025) · doi:10.1101/2025.02.27.640681 · Cited by 13
Self-citationPublic Health and Clinical Implications of Nutrition-Infection Interactions
Vermund, S. H., Scott, M. E., & Humphries, D. L. (2021) · Nutrition and Infectious Diseases · doi:10.1007/978-3-030-56913-6_16 · Cited by 5
Metadata
- Authors
- Soleimany, A. P., & Bhatia, S. N.
- Venue
- Trends in Molecular Medicine
- Publisher
- Elsevier BV
- Published
- 2020-05
- Volume
- 26
- Issue
- 5
- Pages
- 450-468
- ISSN
- 1471-4914 (ISSN-L)
- OpenAlex
- W3014577841
- Cited by
- 92
- References
- 19
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring. https://app.cochat.ai/papers/10.1016/j.molmed.2020.01.013
- The paper
- Soleimany, A. P., & Bhatia, S. N. (2020). Activity-Based Diagnostics: An Emerging Paradigm for Disease Detection and Monitoring. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2020.01.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.